The neuroprotective function of rhEPO was found to follow a bell-shaped dose–response curve both in vitro and in vivo without toxicity even at the highest concentration tested (8 U/eye), which suggests that EPO is a promising therapeutic molecule against neuronal apoptosis in glaucoma and neurodegenerative diseases. The gene discussed is EPO; the disease is glaucoma.